top of page
Gradient-Moving.gif

Advanced Targeted Radiofluorescence & Therapy

Forging our goal of self-guided surgeries

01

Multimodality Radioligand Theranostic Novel Drug For Disease Management

At Antelope Surgical Solutions, Inc., we are driven by our passion for developing cutting-edge products that will revolutionize the medical biotechnology industry. Since our founding in 2020, we’ve established a GMP manufacturing facility equipped with robotic high-throughput synthesis capabilities and received our first FDA IND clearance for our lead agent. Our innovative multimodal small molecule, designed for diagnostic, radiotherapeutic, and fluorescence-guided surgical applications, is built upon our patent pending, first-of-its-kind chemical syntheses. With a team of experts, we are committed to inspiring and leading with our groundbreaking ideas and expertise. 

02

Tenets

01

Definitive In Vivo Identification of Tumors & Metastases during surgery

PET, MR, CT, US, and SPECT imaging techniques often lack the resolution needed to accurately define the spatial boundaries of lymph node metastases and positive margins, limiting the crucial information available to surgeons during procedures. Antelope Surgical Solutions has promising preliminary data in fluorescence-guided surgery and is actively working on developing additional imaging agents for future applications to enhance surgical precision. FDA IND cleared Phase I/II begins summer 2025. 

02

GMP Synthesis

Development pipelines for single-modality diagnostic imaging agents typically take 8 to 10 years and cost between $100-200 million. Antelope Surgical's current pipeline includes two imaging agents, with plans to expand and introduce more in the future. 

03

Proprietary Solutions

We aim to have the first multimodality radioligand therapeutic and fluorescent agent approved by the US Food and Drug Administration on the market.

03

Background Science

01

What is "radio" in radiopharmaceuticals?

Imagine materials so powerful, they can alter the very fabric of matter. Welcome to the world of radioactive materials. The story of radioactivity begins in the late 19th century with Henri Becquerel and is revolutionized by Marie Curie, who truly unlocked its mysteries, coining the term 'radioactivity.' Through her pioneering research, she discovered the elements polonium and radium. Radioactive materials are like time bombs at the atomic level. They have unstable nuclei that lose energy by emitting radiation. This process, called radioactive decay, comes in three flavors: alpha, beta, and gamma decay. From powering life-saving medical treatments to lighting up our homes through nuclear energy, radioactive materials have countless applications. They're even used in smoke detectors! But with great power comes great responsibility. Proper handling and disposal of radioactive waste are crucial to protect ourselves and our environment. Radioactive materials have transformed our world in incredible ways. As we continue to harness their power, we must also respect their potential dangers.

02

What are the 3 primary types of radiation emitted by radiactive materials?

In radioactivity, alpha (α), beta (β), and gamma (γ) radiation are the three primary types of radiation emitted by radioactive materials. They differ in terms of their composition, penetration power, and the way they interact with matter. Alpha Radiation (α): Composition: Alpha particles are made up of 2 protons and 2 neutrons, which is essentially a helium nucleus. Charge: Positive (+2 charge). Penetration: Alpha particles are the least penetrating form of radiation. They can be stopped by a sheet of paper or even the outer layer of human skin. However, if inhaled or ingested, they can cause significant damage to living tissues. Examples: Emitted by heavy elements like uranium-238, radon-222, and plutonium-239. Beta Radiation (β): Composition: Beta particles are high-energy, high-speed electrons (β-) or positrons (β+). Charge: Beta-minus (β-) particles are negatively charged, while beta-plus (β+) particles are positively charged. Penetration: Beta particles are more penetrating than alpha particles but can be stopped by materials like plastic, glass, or a few millimeters of aluminum. Beta radiation can penetrate skin but is usually not as dangerous internally as alpha radiation. Examples: Carbon-14 and strontium-90 emit beta radiation. Gamma Radiation (γ): Composition: Gamma rays are electromagnetic waves (photons), similar to X-rays, but with much higher energy. Charge: Neutral (no charge). Penetration: Gamma rays are the most penetrating form of radiation. They can pass through the human body and require thick lead or several inches of concrete to be fully blocked. Examples: Often emitted alongside alpha or beta decay, such as in the decay of cobalt-60 or cesium-137. In summary: - **Alpha radiation**: Heavy, highly ionizing, but low penetration. - **Beta radiation**: Lighter, moderately ionizing, with medium penetration. - **Gamma radiation**: No mass, very low ionization, but high penetration.have unstable nuclei that lose energy by emitting radiation. This process, called radioactive decay, comes in three flavors: alpha, beta, and gamma decay. From powering life-saving medical treatments to lighting up our homes through nuclear energy, radioactive materials have countless applications. They're even used in smoke detectors! But with great power comes great responsibility. Proper handling and disposal of radioactive waste are crucial to protect ourselves and our environment. Radioactive materials have transformed our world in incredible ways. As we continue to harness their power, we must also respect their potential dangers.

03

What are radioligands?

Radioligands are specialized molecules used in medical and biological research to study receptors or proteins within cells. They are typically radioactive isotopes bound to a ligand (a molecule that binds to a specific site on a receptor). Radioligands allow scientists to visualize or measure how these molecules interact with receptors in real-time, often using techniques like positron emission tomography (PET) or single-photon emission computed tomography (SPECT). Radioligands play a crucial role in drug development, neuroscience, and diagnosing diseases like cancer by helping identify receptor locations and activity, which in turn provides insight into cellular functions and potential therapeutic targets.

04

What is fluorescence-guided surgery?

Fluorescence-guided surgery (FGS) is an advanced technique that helps surgeons visualize and precisely remove tumors or other target tissues using fluorescent dyes. In this procedure, a special fluorescent dye (a contrast agent) is injected into the patient, which selectively binds to the target tissue, such as a tumor. When illuminated with a specific wavelength of light, the dye emits a fluorescent glow, making the targeted tissue stand out from the surrounding healthy tissue. The surgeon uses a special imaging system during the operation to detect the fluorescence, allowing for: Better Visualization: It helps in identifying tumor margins more clearly, ensuring more complete tumor removal. Improved Accuracy: FGS enables the surgeon to distinguish between healthy and diseased tissue in real time. Minimally Invasive Surgery: The enhanced visualization allows for smaller incisions and more precise targeting, reducing damage to healthy tissues. FGS is particularly beneficial in cancer surgeries (e.g., brain, melanoma, or prostate cancer), where it’s crucial to remove all cancerous tissue while preserving as much healthy tissue as possible. The technique is gaining popularity due to its ability to improve surgical outcomes and reduce the chances of recurrence.

04

Redefining the Field of Image Guided Surgery

Dark-wpurprle.png

04

Capabilities

01

Aerodynamics & Propulsion

02

Avionics & Control Systems

03

Materials Science & Structures

04

Artificial Intelligence & Robotics

05

Cybersecurity & Data Protection

05

Press

EIN PRESSWIRE
June 6, 2025

Antelope Surgical Solutions to Present at BIO International Convention 2025

AP News
January 9, 2025

Antelope Surgical Solutions and SHINE Announce Partnership to Advance Clinical Radiopharmaceutical Development

EIN PRESSWIRE
June 6, 2025

Antelope Surgical Solutions to Present at BIO International Convention 2025

AP News
January 9, 2025

Antelope Surgical Solutions and SHINE Announce Partnership to Advance Clinical Radiopharmaceutical Development

BENZINGA
December 20, 2024

Primo Biotechnology Partners with Antelope Surgical Solutions for First FDA-Approved Phase I/II Trial of AS1986NS

AP News
November 12, 2024

Antelope Surgical Solutions Achieves Commercial Investigational New Drug (IND) Approval for PSMA-Fluorescent Novel Drug AS1986NS

Antelope-1-targeted-color-gradient-indigo_edited.jpg

“The future of surgery is AI-guided. Surgeon-led. Antelope-powered.”

06

Contact Us

Ready to Partner with Us?
Contact us today.

bottom of page